| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |